76 Live Notices for 抗肿瘤剂招标
Showing 1 to 20
Drug Formulation And Development
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs As Well As Andexanet Alfa And Eptacog Alfa
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs, Including Elotuzumab, Bimekizumab, Ropeginterferon
Spares Of Vaccine Freeze Dryer And Others
Accessories Of Production Lines And Others For Vaccines
Kcc/Won/Xen-C/2023-24/G-14 Purchase Of 2000 (Two Thousand) Liter Larviside Killing For Mosquito Larva.
Procurement Of Chemical Re-Agent For The F.Y. 2024-2025 In 250 Bed General Hospital, Bhola.
Procurement Of Chemical Reagent For The F.Y. 2024-2025 At Khadimpara 31 Bed Hospital, Sylhet.
Purchase And Successive Delivery Of Oncological And Miscellaneous Drugs.
Delivery Of Medicinal Products And Medical Devices To The Military Medical Institute - National Research Institute
Acquisition Of Antineoplastic Agents And Immunomodulators Group Medicines No. 2 (Oncological Medications) For The Hospital Pharmacy Technical Unit
Supply Of Msr Group-C (Medicine & Surgical Instrument)-Lot-3 Code No 3252105 At Rajshahi Medical College Hospital During The Fy: 2024-25.
Supply Of Msr Group-B (Gauge, Bandage & Cotton)-Lot-3 Code No 3252105 At Rajshahi Medical College Hospital During The Fy: 2024-25.
Supply Of Msr Group-B (Gauge, Bandage & Cotton)-Lot-2 Code No 3252105 At Rajshahi Medical College Hospital During The Fy: 2024-25.
Supply Of Msr Group-A (Medicine)-Lot-2 Code No 3252105 At Rajshahi Medical College Hospital During The Fy: 2024-25.
Supply Of Msr Group-B (Gauge, Bandage & Cotton)-Lot-1 Code No 3252105 At Rajshahi Medical College Hospital During The Fy: 2024-25.
Supply Of Msr Group-A (Medicine)-Lot-1 Code No 3252105 At Rajshahi Medical College Hospital During The Fy: 2024-25.
Supply Of Msr Group-A (Medicine)-Lot-4 Code No 3252105 At Rajshahi Medical College Hospital During The Fy: 2024-25.
Purchase And Successive Delivery Of Oncological And Miscellaneous Drugs.
Delivery Of Medicinal Product: Pembrolizumab